menu
    • menu

    Company profile for Moffitt Cancer Center

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cancer operates on fear. But cancer has one fear of its own: courage. At Moffitt Cancer Center we see that courage every day. And it inspires us to do things differently. As Florida’s only National Cancer Institute-designated Comprehensive Cancer Center and one of only 30 leading cancer centers in the U.S. participating in the National Comprehensive Cancer Network, Moffitt is at the very forefront of cancer centers worldwide...
    Cancer operates on fear. But cancer has one fear of its own: courage. At Moffitt Cancer Center we see that courage every day. And it inspires us to do things differently. As Florida’s only National Cancer Institute-designated Comprehensive Cancer Center and one of only 30 leading cancer centers in the U.S. participating in the National Comprehensive Cancer Network, Moffitt is at the very forefront of cancer centers worldwide in pioneering advances like CAR T-cell therapy. Moffitt is committed to the health and safety of our patients. That’s why we think and act differently, matching the courage of our patients with the courage.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Moffitt Cancer CenterUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    12902 USF Magnolia Drive, Tampa, FL 33612
    Telephone
    Telephone
    813-745-8111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://moffitt.org/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moffitt Cancer Center Partners with Cryoport
    Moffitt Cancer Center Partners with Cryoport

    14 Jan 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/moffitt-cancer-center-partners-with-cryoport/

    CONTRACTPHARMA
    14 Jan 2025
    Share Share
    First Patient Enrolled in STK11 Lung Cancer Phase I at Moffitt
    First Patient Enrolled in STK11 Lung Cancer Phase I at Moffitt

    24 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/24/2952105/37414/en/First-Patient-Enrolled-in-Phase-I-Program-in-STK11-Mutant-Non-Small-Cell-Lung-Cancer-at-Moffitt-Cancer-Center.html

    GLOBENEWSWIRE
    24 Sep 2024
    Share Share
    Moffitt and Fulgent Pharma partner on personalised cancer therapies
    Moffitt and Fulgent Pharma partner on personalised cancer therapies

    15 May 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/moffitt-fulgent-pharma-cancer-therapies/

    PHARMACEUTICAL TECHNOLOGY
    15 May 2024
    Share Share
    Moffitt, Fulgent Pharma Partner To Revolutionize Cancer Therapeutics
    Moffitt, Fulgent Pharma Partner To Revolutionize Cancer Therapeutics

    14 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240514935253/en

    BUSINESSWIRE
    14 May 2024
    Share Share
    Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial
    Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial

    16 Aug 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/anixa-ovarian-cancer-cell-therapy/

    CLINICALTRIALSARENA
    16 Aug 2022
    Share Share
    Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance
    Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance

    30 Aug 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/anixa-biosciences-and-moffitt-cancer-center-announce-fda-clearance-to-initiate-clinical-trial-of-ovarian-cancer-car-t-immunotherapy-301364747.html

    PRNEWSWIRE
    30 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search